The overexpression of POSTN is related to the clinical stage, degree of malignancy, lymph node metastasis, and OS in NSCLC patients, and it is also an independent risk factor for OS in NSCLC patients. This evidence concerns the gene POSTN and metastatic malignant neoplasm in the lymph nodes.